Collectively, Hsa-miR-494-3p may be used as an early diagnostic marker and a good prognostic predictor of CSA-AKI, and miR-494-3p/HtrA3 axis may serve as a novel therapeutic target for CSA-AKI. Here, HTRA3 is linked to acute kidney injury.